☆ 4.7 Letter

Is the pneurnococcal polysaccharide vaccine effective in preventing pneumonia?

LANCET INFECTIOUS DISEASES (2008)

Journal

LANCET INFECTIOUS DISEASES

Volume 8, Issue 7, Pages 405-406

Publisher

ELSEVIER SCI LTD

DOI: 10.1016/S1473-3099(08)70134-8

Keywords

-

Categories

Infectious Diseases

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Microbiology

23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type Streptococcus pneumoniae

Thomas Chandler, Stephen Furmanek, Ruth Carrico, Dawn Balcom, Forest Arnold, Julio Ramirez

Summary: This study analyzed the effectiveness of the 23-valent pneumococcal polysaccharide vaccine (PPSV23) for preventing hospitalization due to serotype-specific community-acquired pneumonia (CAP). The results showed that PPSV23 did not offer protection against CAP hospitalization caused by the vaccine-contained serotypes. This study highlights the importance of developing more effective vaccines for the prevention of hospitalization due to S. pneumoniae CAP.

MICROORGANISMS (2022)

Add to Collection

Article Medicine, General & Internal

CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study

Enny S. Paixao, Kerry L. M. Wong, Flavia Jose Oliveira Alves, Vinicius de Araujo Oliveira, Thiago Cerqueira-Silva, Juracy Bertoldo Junior, Tales Mota Machado, Elzo Pereira Pinto Junior, Viviane S. Boaventura, Gerson O. Penna, Guilherme Loureiro Werneck, Laura C. Rodrigues, Neil Pearce, Mauricio L. Barreto, Manoel Barral-Netto

Summary: The study in Brazil estimated the vaccine effectiveness of CoronaVac in pregnant women, finding that a complete regimen of the vaccine was effective in preventing symptomatic COVID-19 and highly effective against severe illness.

BMC MEDICINE (2022)

Add to Collection

Article Multidisciplinary Sciences

Cross-sectional study on the prevalence of influenza and pneumococcal vaccination and its association with health conditions and risk factors among hospitalized multimorbid older patients

Dimitrios David Papazoglou, Oliver Baretella, Martin Feller, Cinzia Del Giovane, Elisavet Moutzouri, Drahomir Aujesky, Matthias Schwenkglenks, Denis O'Mahony, Wilma Knol, Olivia Dalleur, Nicolas Rodondi, Christine Baumgartner

Summary: The uptake of influenza and pneumococcal vaccination among European older adults with multiple chronic conditions remains low, and is determined by comorbidities and number of health care contacts, especially outpatient medical visits.

PLOS ONE (2021)

Add to Collection

Article Multidisciplinary Sciences

Immunization with lytic polysaccharide monooxygenase CbpD induces protective immunity against Pseudomonas aeruginosa pneumonia

Fatemeh Askarian, Chih-Ming Tsai, Gabriele Cordara, Raymond H. Zurich, Elisabet Bjanes, Ole Golten, Henrik Vinther Sorensen, Armin Kousha, Angela Meier, Elvis Chikwati, Jack-Ansgar Bruun, Judith Anita Ludviksen, Biswa Choudhury, Desmond Trieu, Stanley Davis, Per Kristian Thoren Edvardsen, Tom Eirik Mollnes, George Y. Liu, Ute Krengel, Douglas J. Conrad, Gustav Vaaje-Kolstad, Victor Nizet

Summary: The study reveals the virulence role of Pseudomonas aeruginosa (PA) CbpD in PA pneumonia, which is related to the impairment of the host complement function and opsonophagocytic clearance. The research shows that a PAΔCbpD mutant is more easily cleared and causes less mortality compared to the wild-type strain. Furthermore, the study provides insights into the structure and immunogenicity of CbpD, laying the foundation for the development of novel and effective vaccine antigens.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Bletilla striata polysaccharide microneedle for effective transdermal administration of model protein antigen

Ping Zhou, Shiyi Zhao, Chi Huang, Yan Qu, Chen Zhang

Summary: The study successfully prepared and characterized Bletilla striata polysaccharide microneedles (BMNs) and investigated their potential as a vaccine carrier. BMNs exhibited excellent mechanical properties and stability, good cell compatibility, and slight irritation to the skin.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)

Add to Collection

Article Oncology

Impact of 23-valent pneumococcal polysaccharide vaccination on the frequency of pneumonia-related hospitalization and survival in elderly patients with prostate cancer: A seven-year nationwide matched cohort study

Chung-Yi Li, Liang-Cheng Chen, Hon-Yi Lin, Moon-Sing Lee, Shih-Kai Hung, Chun-Liang Lai, Li-Wen Huang, Ben-Hui Yu, Feng-Chun Hsu, Wen-Yen Chiou

Summary: Vaccination of elderly patients with prostate cancer using PPSV23 significantly decreases the risk of bacterial pneumonia hospitalizations and improves overall survival in Taiwan.

CANCER (2021)

Add to Collection

Article Immunology

Incremental effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia hospitalisation among Australian Indigenous children: A record linkage study

Alamgir Kabir, Deborah Randall, Anthony T. Newall, Hannah C. Moore, Sanjay Jayasinghe, Parveen Fathima, Bette Liu, Peter Mcintyre, Heather F. Gidding

Summary: The impact of the 23-valent pneumococcal polysaccharide vaccine (PPV23) on hospitalization for pneumonia was evaluated in Indigenous children in Western Australia. The study found that there was no statistically significant reduction in overall pneumonia hospitalization rates with PPV23, but the effectiveness varied for different categories of pneumonia. Larger studies controlling for confounding factors are needed to further assess the vaccination.

VACCINE (2023)

Add to Collection

Article Medicine, General & Internal

Community-Acquired Pneumococcal Pneumonia in Highly Vaccinated Population: Analysis by Serotypes, Vaccination Status, and Underlying Medical Conditions

Hakjun Hyun, A-Yeung Jang, Jin Woong Suh, In-Gyu Bae, Won Suk Choi, Yu Bin Seo, Jacob Lee, Jin Gu Yoon, Ji Yun Noh, Hee Jin Cheong, Woo Joo Kim, Min Ja Kim, Joon Young Song

Summary: The serotype distribution of pneumococcus in South Korea is evolving, which hinders vaccine rollout. Despite vaccination efforts, serotypes 3 and 19A remain the most common in pneumococcal pneumonia cases in South Korea.

JOURNAL OF KOREAN MEDICAL SCIENCE (2023)

Add to Collection

Article Respiratory System

Effectiveness of a 23-valent pneumococcal polysaccharide vaccine for the prevention of pneumococcal pneumonia in the elderly with chronic respiratory diseases: a case-control study of a single center

Toshihiro Masuda, Eiji Nakatani, Toshihiro Shirai, Taisuke Akamatsu, Kanami Tamura, Shingo Takahashi, Yuko Tanaka, Hirofumi Watanabe, Yoshinari Endo, Takahito Suzuki, Mika Saigusa, Akito Yamamoto, Satoru Morita, Yoko Sato, Kazuhiro Asada

Summary: This study suggests that PPSV23 can be useful in preventing pneumococcal pneumonia in elderly outpatients with chronic respiratory diseases, especially in age groups of 70 and above and 75 and above.

BMC PULMONARY MEDICINE (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among US Adults: Updated Recommendations of the Advisory Committee on Immunization Practices-United States, 2022

Miwako Kobayashi, Jennifer L. Farrar, Ryan Gierke, Amadea Britton, Lana Childs, Andrew J. Leidner, Doug Campos-Outcalt, Rebecca L. Morgan, Sarah S. Long, H. Keipp Talbot, Katherine A. Poehling, Tamara Pilishvili

Summary: This report highlights the revised pneumococcal vaccination recommendations for U.S. adults. For PCV-naive adults aged >= 65 years or aged 19-64 years with certain underlying conditions, the Advisory Committee on Immunization Practices now recommends either 15-valent PCV (PCV15) or 20-valent PCV (PCV20). When PCV15 is used, a dose of 23-valent pneumococcal polysaccharide vaccine (PPSV23) should be administered at least 1 year later.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Synthetic Pseudaminic-Acid-Based Antibacterial Vaccine Confers Effective Protection against Acinetobacter baumannii Infection

Ruohan Wei, Xuemei Yang, Han Liu, Tongyao Wei, Sheng Chen, Xuechen Li

Summary: The study demonstrates that chemically synthesized Pse-CRM197 conjugates can stimulate high immune responses and provide a new alternative for controlling infections caused by multidrug-resistant A. baumannii.

ACS CENTRAL SCIENCE (2021)

Add to Collection

Article Multidisciplinary Sciences

Optimal age targeting for pneumococcal vaccination in older adults; a modelling study

Deus Thindwa, Samuel Clifford, Jackie Kleynhans, Anne von Gottberg, Sibongile Walaza, Susan Meiring, Todd D. Swarthout, Elizabeth Miller, Peter McIntyre, Nick Andrews, Zahin Amin-Chowdhury, Norman Fry, Kondwani C. Jambo, Neil French, Samanta Cristine Grassi Almeida, Shamez N. Ladhani, Robert S. Heyderman, Cheryl Cohen, Maria Cristina de Cunto Brandileone, Stefan Flasche

Summary: The risk of invasive pneumococcal disease (IPD) increases with age for older adults, but the population benefiting from pneumococcal vaccines and the immunogenic response to vaccination decline. This study examined the impact of demographics, vaccine efficacy, and waning efficacy on the optimal age for pneumococcal vaccination. The findings suggest that administering pneumococcal vaccines earlier in adulthood in low/middle-income countries could prevent a significant proportion of residual IPD burden.

NATURE COMMUNICATIONS (2023)

Add to Collection

Review Immunology

Preventing the Next Pandemic: Is Live Vaccine Efficacious against Monkeypox, or Is There a Need for Killed Virus and mRNA Vaccines?

Abdelaziz Abdelaal, Abdullah Reda, Basant Ismail Lashin, Basant E. Katamesh, Aml M. Brakat, Balqees Mahmoud AL-Manaseer, Sayanika Kaur, Ankush Asija, Nimesh K. Patel, Soney Basnyat, Ali A. Rabaan, Saad Alhumaid, Hawra Albayat, Mohammed Aljeldah, Basim R. Al Shammari, Amal H. Al-Najjar, Ahmed K. Al-Jassem, Sultan T. AlShurbaji, Fatimah S. Alshahrani, Ahlam Alynbiawi, Zainab H. Alfaraj, Duaa H. Alfaraj, Ahmed H. Aldawood, Yub Raj Sedhai, Victoria Mumbo, Alfonso J. Rodriguez-Morales, Ranjit Sah

Summary: Monkeypox virus is a member of the Poxviridae family and the actual reservoir for the virus is still unknown. Three vaccines are available to prevent orthopoxviruses, but there is a need for the development of a new generation vaccine specifically for monkeypox.

VACCINES (2022)

Add to Collection

Review Cell Biology

Are beta blockers effective in preventing stroke-associated infections? - a systematic review and meta-analysis

Li Yang, Xiang Wenping, Zhang Jinfeng, Pang Jiangxia, Wang Jingbo, Wang Baojun

Summary: Although beta blockers treatment may be associated with an increased risk of post-stroke urinary tract infection and stroke associated pneumonia in some stroke patients, this meta-analysis did not find significant associations between beta blockers therapy and the prevention of stroke associated infection.

AGING-US (2022)

Add to Collection

Article Chemistry, Analytical

Validation of an FFF-MALS Method to Characterize the Production and Functionalization of Outer-Membrane Vesicles for Conjugate Vaccines

Robert M. F. van der Put, Arnoud Spies, Bernard Metz, Daniel Some, Roger Scherrers, Roland Pieters, Maarten Danial

Summary: In this study, a FFF-MALS method was developed for the characterization of OMVs, and NIST-traceable particle-size standards and BSA were used for validation. The validation results showed excellent accuracy and reliability of the method. Furthermore, the validated method was used for the characterization of a purification process and different OMVs from bacterial origin. Lastly, functionalization of OMVs did not affect their structural integrity, as evaluated by the validated FFF-MALS method.

ANALYTICAL CHEMISTRY (2022)

Add to Collection

Article Clinical Neurology

Incidence and risk conditions of ischemic stroke in older adults

E. Satue, A. Vila-Corcoles, O. Ochoa-Gondar, C. de Diego, M. J. Forcadell, T. Rodriguez-Blanco, L. Barnes, M. Jariod

ACTA NEUROLOGICA SCANDINAVICA (2016)

Add to Collection

Article Infectious Diseases

Incidence and lethality of invasive pneumococcal disease in Tarragona, Spain, 2006-2009

Angel Vila-Corcoles, Elisabet Salsench-Serrano, Olga Ochoa-Gondar, Carlos Aguirre-Chavarria, Jesus Utrera-Aponte, Jorge Guzman-Avalos

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2015)

Add to Collection

Article Infectious Diseases

Influence of chronic illnesses and underlying risk conditions on the incidence of pneumococcal pneumonia in older adults

Angel Vila-Corcoles, Carlos Aguirre-Chavarria, Olga Ochoa-Gondar, Cinta de Diego, Teresa Rodriguez-Blanco, Frederic Gomez, Xavier Raga, Luis Barnes, Ramon Magarolas, Leonardo Esteban

INFECTION (2015)

Add to Collection

Article Otorhinolaryngology

Epidemiology of Streptococcus pneumoniae causing acute otitis media among children in Southern Catalonia throughout 2007-2013: Incidence, serotype distribution and vaccine's effectiveness

O. Ochoa-Gondar, E. Figuerola-Massana, A. Vila-Corcoles, C. A. Aguirre, C. de Diego, E. Satue, F. Gomez, X. Raga

INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY (2015)

Add to Collection

Article Medicine, General & Internal

Pneumococcal pneumonia in adults 60 years or older: Incidence, mortality and prevention

Angel Vila-Corcoles, Xabier Ansa, Olga Ochoa-Gondar, Eva Satue, Cinta de Diego, Teresa Rodriguez-Blanco

MEDICINA CLINICA (2016)

Add to Collection

Article Biotechnology & Applied Microbiology

Pneumococcal vaccination coverages among low-, intermediate-, and high-risk adults in Catalonia

Angel Vila-Corcoles, Olga Ochoa-Gondar, Imma Hospital, Cinta de Diego, Eva Satue, Jordi Blade, Xabier Ansa, Jorge A. Guzman, Elisabet Salsench, Francisca Ramos

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)

Add to Collection

Article Immunology

Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine Against Community-Acquired Pneumonia in the General Population Aged ≥60 Years: 3 Years of Follow-up in the CAPAMIS Study

Olga Ochoa-Gondar, Angel Vila-Corcoles, Teresa Rodriguez-Blanco, Frederic Gomez-Bertomeu, Enric Figuerola-Massana, Xavier Raga-Luria, Imma Hospital-Guardiola

CLINICAL INFECTIOUS DISEASES (2014)

Add to Collection

Article Infectious Diseases

Validation of the CORB75 (confusion, oxygen saturation, respiratory rate, blood pressure, and age ≥75 years) as a simpler pneumonia severity rule

O. Ochoa-Gondar, A. Vila-Corcoles, T. Rodriguez-Blanco, I. Hospital, E. Salsench, X. Ansa, N. Saun

INFECTION (2014)

Add to Collection

Article Neurosciences

Evaluating Clinical Effectiveness of Pneumococcal Vaccination in Preventing Stroke: The CAPAMIS Study, 3-Year Follow-up

Angel Vila-Corcoles, Olga Ochoa-Gondar, Teresa Rodriguez-Blanco, Cinta de Diego-Cabanes, Eva Satue-Gracia, Angel Vila-Rovira, Cristina Torrente Fraga

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2014)

Add to Collection

Editorial Material Infectious Diseases

Pneumococcal conjugate vaccination: correlates of protection

Angel Vila-Corcoles, Olga Ochoa-Gondar

LANCET INFECTIOUS DISEASES (2014)

Add to Collection

Article Immunology

Evaluating the clinical effectiveness of pneumococcal vaccination in preventing myocardial infarction: The CAPAMIS study, three-year follow-up

O. Ochoa-Gondar, A. Vila-Corcoles, T. Rodriguez-Blanco, C. de Diego-Cabanes, I. Hospital-Guardiola, M. Jariod-Pamies

VACCINE (2014)

Add to Collection

Article Primary Health Care

Pneumococcal disease in adults: Risk levels and vaccine recommendations

Angel Vila-Corcoles, Olga Ochoa-Gondar

ATENCION PRIMARIA (2017)

Add to Collection

Article Public, Environmental & Occupational Health

Estimates of Target Population for Pneumococcal Vaccination in People over 50 years in Catalonia and Spain

Angel Vila-Corcoles, Olga Ochoa-Gondar, Eva Satue, Marc Vila-Rovira, Manel Jariod

REVISTA ESPANOLA DE SALUD PUBLICA (2017)

Add to Collection

Article Microbiology

Prevalence of serotypes causing invasive pneumococcal disease in the region of Tarragona, Spain, 2006-2009: vaccine-serotype coverage for the distinct antipneumococcal vaccine formulations

Olga Ochoa-Gondar, Frederic Gomez-Bertomeu, Angel Vila-Corcoles, Xavier Raga, Carlos Aguirre, Jesus Utrera, Cinta de Diego, Jorge A. Guzman, Enric Figuerola

REVISTA ESPANOLA DE QUIMIOTERAPIA (2015)

Add to Collection

Article Clinical Neurology

Incidence and lethality of ischaemic stroke among people 60 years or older in the region of Tarragona (Spain), 2008-2011

Angel Vila-Corcoles, Eva Satue-Gracia, Olga Ochoa-Gondar, Cinta de Diego-Cabanes, Angel Vila-Rovira, Jordi Blade, Francesc Bobe, Raquel Casanova, Manuel Jariod, Rosaura Reig

REVISTA DE NEUROLOGIA (2014)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.